Comunicati.net - Comunicati pubblicati - Editoria Comunicati.net - Comunicati pubblicati - Editoria Fri, 21 Feb 2020 19:50:03 +0100 Zend_Feed_Writer 1.12.20 (http://framework.zend.com) http://zend.comunicati.net/comunicati/aziende/editoria/1 Research Report Explores The Glycobiology Market Will Be Valued At US$ 1,670.3 Mn By 2024 Thu, 20 Feb 2020 10:41:11 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/621122.html http://zend.comunicati.net/comunicati/aziende/editoria/621122.html persistencemarketresearch persistencemarketresearch Extensive research related to carbohydrate molecule in various fields such as marine science and food & beverages industry is expected to fuel growth of the global  glycobiology market . The global market is expected to reach a value of  US $ 1,670.3 Mn by 2024 , registering a  CAGR of 12.8% between 2016 and 2024 , according to a new report by Persistence Market Research (PMR).

PMR's report offers market forecast and analysis on the  global glycobiology market , while segmenting the market on the basis of product-type, application, end-user, and region. The report segments the global glycobiology market into five key regions: North America, Latin America, Europe, Middle East and Africa (MEA), and Asia Pacific (APAC). According to PMR regional analysis, North America (including the US and Canada) is the most lucrative market for glycobiology globally.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/4769

Key Findings of the Report:

  • To investigate the  competitive landscape  - product launches, expansions, collaborations and acquisitions in the market.
  • To analyze and research the global market landscape and  growth outlook , which includes, revenue, production, consumption, historical and forecast.
  • To recognize important drivers, restraints, opportunities, and threats ( DROT  Analysis) ( SWOT  Analysis).
  • To tactically examine the growth pattern and contribution to the market of every segment.

This region is expected to account for highest market share over the forecast period (2016–2024) and is expected to exhibit a significantly high growth rate. Asia Pacific is expected to be the fastest growing market in the global glycobiology market owing to increasing awareness amongst researchers regarding the various benefits of research related to carbohydrate molecules and its association with novel drug development. APAC is estimated to account for around 19.1% revenue share in the global glycobiology market by the end of 2016.

MEA region is also expected to register significant growth over the forecast period owing to increasing R&D expenditure by pharmaceutical industries. This region is expected to register a CAGR of 11.0% over the forecast period.

On the basis of product type, PMR has segmented the glycobiology market into instruments, enzymes, consumables and reagent kits segments. Enzymes product type segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Enzyme product type segment accounted for 52.6% revenue share in 2015.

Due to high adoption rate of enzymes to conduct various research initiatives, this segment is expected to witness high incremental opportunity globally.

For Critical Insights On The Glycobiology Market, Request For Customization Here @ https://www.persistencemarketresearch.com/request-customization/4769

On the basis of application, PMR has segmented the glycobiology market into drug discovery and development, therapeutic application, diagnostic application, industrial application, and others segments. Drug discovery and development application segment is expected to dominate the market and is anticipated to be the most lucrative segment growing at a CAGR of 13.4% over the forecast period.

On the basis of end user, the glycobiology market has been segmented into biopharmaceutical companies, research laboratories, hospitals, diagnostic centers, contract research organization, biotechnology industry, academic institutes, and others. PMR estimates that biopharmaceutical companies end user segment is expected to account for highest revenue share in the global glycobiology market and is expected to witness fastest growth over the forecast period.

Factors such as increasing demand for novel drug development, especially for chronic diseases such as cancer and diabetes, is expected to boost revenue share contribution from the biopharmaceutical companies segment. Research laboratories segment is also expected to register a significant growth rate during the forecast period.

The report discusses several factors affecting the global glycobiology market such as increment in R&D expenditure, key strategies of participant companies, and regional trends.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/4769

]]>
Attractive Market Opportunities In The Medical Imaging Equipment Market By 2023 Thu, 20 Feb 2020 10:30:20 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/621117.html http://zend.comunicati.net/comunicati/aziende/editoria/621117.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research " Global Market Study on Medical Imaging Equipment,"  the  global medical imaging equipment market  was  valued at US $ 29.4 Bn in 2015  and is expected to reach  US $ 45.3 Bn by 2023 , growing at a  CAGR of 5.6%  during the forecast period from 2015 to 2023.

Improvement in health care reforms in major countries such as Japan, the U.S., China, and U.K. has enhanced access to various diagnostic and treatment services thereby increasing life expectancy of the population. Rise in geriatric population is expected to intensify the need for healthcare products and services in these countries.

Moreover, the rising incidence of diseases across the globe continue to increase the demand for diagnosis equipment, particularly non-invasive imaging solutions. According to the World Health Organization (WHO), an estimated 17.5 Mn people died due to cardiovascular diseases in 2012, accounting for approximately 31% of global deaths. Moreover, 235 Mn people were diagnosed with asthma across the world in 2014.

On account of all these factors, the global medical imaging equipment market is expected to grow at a CAGR of 5.6% during the forecast period from 2015 to 2023.  The market is driven by the major developed economies of the U.S., Europe, and Asia Pacific. However, emerging markets, particularly, China, India and Brazil are expected to be the fastest growing market in terms of CAGR during the forecast period.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11215

Key Findings of the Report:

  • To investigate the competitive landscape – product launches, expansions, collaborations and acquisitions in the market.
  • To analyze and research the global market landscape and growth outlook, which includes, revenue, production, consumption, historical and forecast.
  • To recognize important drivers, restraints, opportunities, and threats (DROT Analysis)(SWOT Analysis).
  • To tactically examine the growth pattern and contribution to the market of every segment.
With a share of more than 30% in 2015, North America was the largest market for medical imaging equipment primarily due to high awareness about medical imaging devices financial capability to purchase expensive machines, rising demand for technologically advanced and innovative products in hospitals, diagnostics laboratories and outpatient ambulatory surgery centers, and high investment in improving healthcare infrastructure. Obesity is one of the major causes of several diseases of cardiovascular system that has led to increase in demand for diagnostic imaging in the U.S.

According to the Centers for Disease Control and Prevention (CDC), the percentage of obese children aged between 6 years and 11 years increased from  7% in 1980 to 18% in 2012  in the US In addition, increasing healthcare expenditure in the US in recent years has also assisted in dramatic rise in the usage of medical imaging.

Emerging economies such as China, India, Indonesia, Malaysia, Singapore and Thailand are providing much needed boost to the medical imaging equipment market. The Asia Pacific market is driven by demand for refurbished imaging systems as more equipment are needed with less funds dedicated to healthcare budgets.

For Critical Insights On The Medical Imaging Equipment Market, Request For Customization Here @  https://www.persistencemarketresearch.com/request-customization/11215

However, demand for new devices that offer superior imaging, speed, flexibility and portability are also being adopted in China and India, countries with the largest market potential. Europe was ranked third, in terms of market size, after  North America and Asia Pacific.

Demand in the region is similar to North America, wherein demand for advanced equipment for all modalities is higher. Western Europe, which includes major economies such as Germany, UK, France, and Italy, holds a major share in the region.

Others markets on the global map include Latin America and Middle East & Africa. As the markets in the developed world are becoming saturated, most the market players are focusing on emerging markets in Brazil and member states of Gulf Cooperation Council. Looking at the proximity of Brazil to the US, major market players find it convenient to have manufacturing facilities in Brazil.

Therefore, the Latin America market is poised to grow rapidly. In addition, the government efforts in GCC member states to invest in improving the healthcare infrastructure and promote medical tourism are facilitating the demand for newer medical imaging equipment.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/11215

]]>
Medical Imaging Equipment Market To Witness Robust Expansion Throughout the Forecast 2023 Thu, 20 Feb 2020 10:22:12 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/621116.html http://zend.comunicati.net/comunicati/aziende/editoria/621116.html persistencemarketresearch persistencemarketresearch According to a new market report published by Persistence Market Research " Global Market Study on Medical Imaging Equipment,"  the  global medical imaging equipment market  was  valued at US $ 29.4 Bn in 2015  and is expected to reach  US $ 45.3 Bn by 2023 , growing at a  CAGR of 5.6%  during the forecast period from 2015 to 2023.

Improvement in health care reforms in major countries such as Japan, the U.S., China, and U.K. has enhanced access to various diagnostic and treatment services thereby increasing life expectancy of the population. Rise in geriatric population is expected to intensify the need for healthcare products and services in these countries.

Moreover, the rising incidence of diseases across the globe continue to increase the demand for diagnosis equipment, particularly non-invasive imaging solutions. According to the World Health Organization (WHO), an estimated 17.5 Mn people died due to cardiovascular diseases in 2012, accounting for approximately 31% of global deaths. Moreover, 235 Mn people were diagnosed with asthma across the world in 2014.

On account of all these factors, the global medical imaging equipment market is expected to grow at a CAGR of 5.6% during the forecast period from 2015 to 2023.  The market is driven by the major developed economies of the U.S., Europe, and Asia Pacific. However, emerging markets, particularly, China, India and Brazil are expected to be the fastest growing market in terms of CAGR during the forecast period.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11215

Key Findings of the Report:

  • To investigate the competitive landscape – product launches, expansions, collaborations and acquisitions in the market.
  • To analyze and research the global market landscape and growth outlook, which includes, revenue, production, consumption, historical and forecast.
  • To recognize important drivers, restraints, opportunities, and threats (DROT Analysis)(SWOT Analysis).
  • To tactically examine the growth pattern and contribution to the market of every segment.
With a share of more than 30% in 2015, North America was the largest market for medical imaging equipment primarily due to high awareness about medical imaging devices financial capability to purchase expensive machines, rising demand for technologically advanced and innovative products in hospitals, diagnostics laboratories and outpatient ambulatory surgery centers, and high investment in improving healthcare infrastructure. Obesity is one of the major causes of several diseases of cardiovascular system that has led to increase in demand for diagnostic imaging in the U.S.

According to the Centers for Disease Control and Prevention (CDC), the percentage of obese children aged between 6 years and 11 years increased from  7% in 1980 to 18% in 2012  in the US In addition, increasing healthcare expenditure in the US in recent years has also assisted in dramatic rise in the usage of medical imaging.

Emerging economies such as China, India, Indonesia, Malaysia, Singapore and Thailand are providing much needed boost to the medical imaging equipment market. The Asia Pacific market is driven by demand for refurbished imaging systems as more equipment are needed with less funds dedicated to healthcare budgets.

For Critical Insights On The Medical Imaging Equipment Market, Request For Customization Here @  https://www.persistencemarketresearch.com/request-customization/11215

However, demand for new devices that offer superior imaging, speed, flexibility and portability are also being adopted in China and India, countries with the largest market potential. Europe was ranked third, in terms of market size, after  North America and Asia Pacific.

Demand in the region is similar to North America, wherein demand for advanced equipment for all modalities is higher. Western Europe, which includes major economies such as Germany, UK, France, and Italy, holds a major share in the region.

Others markets on the global map include Latin America and Middle East & Africa. As the markets in the developed world are becoming saturated, most the market players are focusing on emerging markets in Brazil and member states of Gulf Cooperation Council. Looking at the proximity of Brazil to the US, major market players find it convenient to have manufacturing facilities in Brazil.

Therefore, the Latin America market is poised to grow rapidly. In addition, the government efforts in GCC member states to invest in improving the healthcare infrastructure and promote medical tourism are facilitating the demand for newer medical imaging equipment.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/11215

]]>
Transcatheter Heart Valve Replacement Repair Market To Register A Stellar Growth Rate Of CAGR 13.9% During 2026 Thu, 20 Feb 2020 09:55:40 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/621105.html http://zend.comunicati.net/comunicati/aziende/editoria/621105.html persistencemarketresearch persistencemarketresearch According to the latest market report published by Persistence Market Research titled 'Global  Transcatheter Heart Valve Replacement & Repair Market : Global Industry Analysis and Forecast, 2016 - 2026, the global  transcatheter heart valve replacement & repair market  is projected to expand at a  CAGR of 13.9 %  during the forecast period (2016–2026).

Transcatheter heart valve replacement is a relatively non-invasive procedure to repair the damaged heart valves with bioprosthetic valves for treatment of valvular heart disease namely aortic stenosis and mitral regurgitation among geriatric population.

It is an alternative approach to conventional open heart surgery, especially for extremely high risk patients. Transcatheter heart valve replacement & repair market was valued at  US $ 1,605.5 Mn  in 2015 and the revenue is expected to increase to  US $ 6,701.5 Mn by 2026 at a CAGR of 13.9%  over the forecast period.

The report offers market forecast and analysis on global transcatheter heart valve replacement & repair market, segmenting the market on the basis of product type, surgical approach, end user and region. The report segments the global transcatheter heart valve replacement & repair market into seven key regions namely  North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and Middle East and Africa (MEA).

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @  https://www.persistencemarketresearch.com/samples/11167

Key Findings of the Report:

  • To investigate the  competitive landscape  - product launches, expansions, collaborations and acquisitions in the market.
  • To analyze and research the global market landscape and  growth outlook , which includes, revenue, production, consumption, historical and forecast.
  • To recognize important drivers, restraints, opportunities, and threats ( DROT  Analysis) ( SWOT  Analysis).
  • To tactically examine the growth pattern and contribution to the market of every segment.

According to PMR's regional analysis, North America (US and Canada) is the most lucrative market for transcatheter heart valve replacement & repair. This market in the region is expected to account for larger share throughout the forecast period, albeit exhibiting a slow growth rate.

Asia Pacific is expected to be the fastest growing market for transcatheter heart valve replacement & repair, owing to increasing prevalence rate of cardiovascular diseases such as valvular heart disease and rising population in the region. Asia Pacific is estimated to account for 6.2% revenue share by end of 2016 in the transcatheter heart valve replacement & repair market.

For Critical Insights On The Transcatheter Heart Valve Replacement Repair Market, Request For Customization Here @  https://www.persistencemarketresearch.com/request-customization/11167

On the basis of product type, PMR has segmented the transcatheter heart valve replacement & repair market into TAVR (Transcatheter Aortic Valve replacement) and TMVR (Transcatheter Mitral Valve Repair). TAVR segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of TAVR devices across the globe, this segment is expected to witness high incremental opportunity between 2016 and 2026.

On the basis of surgical approach, the transcatheter heart valve replacement & repair market has been segmented into transfemoral approach, transapical approach and transaortic approach. Transfemoral approach segment is expected to dominate the market through the forecast period and is anticipated to be the most lucrative segment. Due to high adoption rate of transfemoral approach by cardiologists, this segment is expected to witness high incremental opportunity.

On the basis of end user, the transcatheter heart valve replacement & repair market has been segmented into hospitals, ambulatory surgical centers and cardiac catheterization laboratories. As per PMR analysis, among end users, the hospitals segment accounted for highest revenue share in 2015 and is expected to witness fastest growth over the forecast period.

This is mainly attributed to increasing patient population seeking effective and efficient treatment with shorter recovery time. Cardiac catheterization laboratory segment is also expected to exhibit significant growth during the forecast period, as it provides better treatment facilities and ease of access.

The report provides in depth insights about several factors such as increment in healthcare expenditure, key strategies of the participant companies, reimbursement policies and regulations affecting the transcatheter heart valve replacement & repair market.

For In-Depth Competitive Analysis, Buy Now @  https://www.persistencemarketresearch.com/checkout/11167

]]>
Rising Demand From Consumers To Push Sales Of Dermal Regeneration Matrix Device Market Wed, 19 Feb 2020 12:27:29 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620950.html http://zend.comunicati.net/comunicati/aziende/editoria/620950.html persistencemarketresearch persistencemarketresearch Currently, topical antibiotics, skin grafting, wound dressings and tissue-engineered substitutes are available in the market that are used to treat skin-related disorders. A skin graft can be done by natural substitute such as amniotic membrane, potato peel or artificial material that includes synthetic polymer sheet, polymer foam or spray.

These substitute helps in the healing process. Skin regeneration refers to the regrowth of the damaged skin from the remaining tissue. Stem cell therapy has a vital application in skin regeneration.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12166  

Dermal regeneration matrix device provides an appropriate environment that is necessary for the proliferation and differentiation of skin cells. It helps in triggering the body‘s own repair mechanism by cell signaling, that drive the matrix environment in wound healing process.

Dermal regeneration matrix device is used to treat skin burns and is also finds application in reconstructive surgery for contractures (scars). The dermal regeneration matrix device is placed over the damaged skin which provides an environment for regeneration of new skin and tissue. The matrix is made of cow collagen, silicone and shark cartilage.

In 1996, the US Food and Drug Administration (FDA) first approved integrates dermal regeneration matrix device for treatment of burn injuries. In 2002, dermal regeneration matrix device was approved for use in reconstructive surgery for burn scars. About 30 million people in the US are suffering from diabetes, of which 15% experience a diabetic foot ulcer in their lifetime.

In January 2016, FDA approved the use of dermal regeneration matrix for treatment of chronic diabetic foot ulcers (DFU). The usage of dermal regeneration matrix device is expected to expand the growth of dermal regeneration matrix device owing to increase usage in chronic foot ulcer.

Technological advancement and continued research in the development of artificial skin promises to bring more products to the marketplace. Increasing adoption of the device and long-term benefits associated with its application are some of the factors expected to fuel growth of the global dermal regeneration matrix device market over the forecast period.  

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12166 

]]>
Single-Use Bioprocess System Market Sales Revenue To Significantly Increase In The Next Few Years Wed, 19 Feb 2020 12:27:07 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620949.html http://zend.comunicati.net/comunicati/aziende/editoria/620949.html persistencemarketresearch persistencemarketresearch Rising adoption of Single-use bioprocess systems in commercial product manufacturing is expected to increase the growth of market. The advantages associated with the device includes reusable device, low operational cost and minimal or no risk of cross contamination. Single-use bioprocess system provides various economic advantages over fixed stainless-steel system.

Flexibility of Single-use bioprocess system allows companies to assemble and store devices as per the need. This technology is used throughout the process of biopharmaceuticals production, starting from buffer or media preparation to culturing of vaccines in bioreactor to storage and shipping of biologics.   

Rising demand for disposables in biopharmaceuticals procedures, rising prevalence of disease requiring for developed drugs for their management and treatment and improved research infrastructure of life science is expected to grow the market. Single-use bioprocess system includes various products. Some of major products related to these are manifold assemblies, single-use bioreactors, containers and bags, support containers and mixers.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12142

These product reduce the cost related to cleaning and sterilization. Increasing stringent regulations on usage of plastic based disposables is expected to be one of the common restrains for this market. Lack of awareness towards innovative products of bioprocess is also expected to hinder the growth of Single-use bioprocess system market.

Global market for Single-use bioprocess system is expected to grow at healthy growth rates owing to growing incidence of various chronic disorders such as neurological and cardiovascular disorders. Other prominent factors fueling the increasing penetration of Single-use bioprocess system includes ease of implants with enhanced clinical performance, strong reimbursements, greater patient awareness and referrals and improved technology enabling market leadership.

The technology proves to be cost effective when compared to alternative therapies with minimal complications. Additionally, reduced medication dosage with minimal side effects Dyskinesia, improved motor symptoms for comparatively longer period of time are some of the other factors that have largely contributed towards higher market growth of Single-use bioprocess system over the forecasted period.

Based on Product type, the global Single-use bioprocess system market is segmented into the following:

Product Type

  • Research and Development (R&D) systems
  • GMP / Commercial production systems

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12142 

]]>
Implantable Cardioverter Defibrillator Market To Witness Heightened Revenue Growth In The Next Decade Wed, 19 Feb 2020 12:26:45 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620948.html http://zend.comunicati.net/comunicati/aziende/editoria/620948.html persistencemarketresearch persistencemarketresearch An  Implantable cardioverter defibrillator  is an instrument that is placed under the skin which is battery powered that monitors the heart rate in the patients with sustained tachycardia or fibrillation. Such devices are very much useful in avoiding impulsive deaths in patients with sustained ventricular tachycardia or fibrillation.

The term Defibrillation is defined as the heart beating dangerously fast and a high-energy shock is delivered to the muscles of the heart in order to restore normal rhythm. Implantable cardioverter defibrillator devices are also known to have a crucial role in avoiding cardiac arrest with previous history and tachycardia associated with pulseless ventricle.

Michel Mirowski invented implantable cardioverter defibrillator device in the late 1960s as his mentor was suffering with recurring ventricular tachyarrhythmia. Implantable cardioverter defibrillators delivers the necessary therapy for maintaining standard heart rhythm.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12109

Programs like cardio and anti-tachycardia pacing can be fed in implantable cardioverter defibrillators.  A chain of minor electrical impulses are carried and delivered to the muscles of heart in order to restore standard heart rate and normal rhythm.

Low level of energy shock is administered simultaneously in order to restore the standard heart rhythm in Cardio. The term Bradycardia pacing denotes slow beating heart. This also means tiny electrical impulses are carried to the heart muscles to stimulate heart muscles in order to maintain appropriate heart rate.

The increasing demand of implantable cardioverter defibrillator devices in the emerging economies like middle east and Asia Pacific is due to rise in the prevalence of cardiovascular disorder including the use of implantable cardioverter devices.

Awareness about the treatment options has improved drastically in the since the last decade which has improved the use of implantable cardioverter defibrillator devices in the above mentioned economies.

There are several training workshops for patients as well as for the surgeons regarding the implantable cardioverter defibrillator devices organized by various manufacturers of implantable cardioverter defibrillator devices which has also led to the increase in the awareness among the surgeon and the patients.

Implantable cardioverter defibrillator market poised to witness significant growth owing to its ability to treat various diseased conditions of heart. Availability of several brands with customization help to boost this market over the forecast period.

However lack of training or skilled professionals to operate and apprehensions about its safety among different population groups may hamper the growth of the Implantable cardioverter defibrillator market over the forecast period.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12109  

]]>
Research Report Explores The Single Port Surgical Platform Market Wed, 19 Feb 2020 12:26:22 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620947.html http://zend.comunicati.net/comunicati/aziende/editoria/620947.html persistencemarketresearch persistencemarketresearch Single port surgical platforms  are also called Single Port Access Surgery (SPA), Single-Incision Laparoscopic Surgery (SILS), and Laparo-endoscopic Single-Site Surgery (LESS). Normally, in abdominal surgeries, large incisions are made to conduct the surgery.       

Although, they are effective but they usually cause postoperative pain, wound infections, and prolonged hospitalization. Current rate of incisional hernia is 4-18% and wound infections are 2-25% in the US whereas, in case of conventional laparoscopic surgeries, multiple incisions are made on the body to conduct the surgery.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11929 

To overcome the above challenges, companies are focusing on developing the novel single-port surgical platform, which creates single incision on the body. This surgical platform also helps in speedy recovery, small incisions, and are less prone to infections and pain conditions. In addition to these, it does not leave any scars on the body after the surgery.

The market is driven mainly by factors such as technological innovations, increase in adoption of SPSP, growing preference towards minimally invasive surgery process, and exploration of their utility in other applications Ex: General Surgery, Gastroenterology, Urology, Gynecology and Bariatric Surgery. Increasing preference towards scar-less slimming surgeries is a major factor responsible for boosting the market growth.

This platform allows surgeons to conduct surgeries in the abdominal cavity by accessing through small holes. Furthermore, SPSP reduces treatment costs by reducing hospital stay of the patients. Hence, patients and surgeons are prefer SPSP as compared to others.

The major constraints of this market are high cost, lack of skilled professionals, and triangulation problems. The single port surgical platform (SPSP) is segmented based on its application and technology.

Segmentation by Application

  • General Surgery
  • Gastroenterology
  • Urological
  • Gynecological
  • Bariatric

Segmentation by Technology

  • Robot / Remote controlled Assisted
  • Manual - Assisted

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11929 

]]>
Opportunity Assessment Of Periodic Fever Syndrome Market Reveals Lucrative Prospects For Manufacturers Wed, 19 Feb 2020 12:25:01 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620946.html http://zend.comunicati.net/comunicati/aziende/editoria/620946.html persistencemarketresearch persistencemarketresearch Despite similarities in symptoms, periodic fever syndrome has different patterns of inheritance, causes, length and frequency of 'attacks.' Some of the chronic condition associated with Periodic Fever Syndrome includes Cryopyrin-associated periodic syndrome (CAPS), hyperimmunoglobulinemia D syndrome (HIDS), TNF receptor-associated periodic syndrome (TRAPS) and Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome (PFAPA) .

The symptoms of Periodic Fever Syndrome are cyclic in nature, coming and going, with the difference in severity.

Periodic Fever Syndrome affects many organs and tissues and has its own set of symptoms along with high temperature during attacks. Elevated serum levels of acute-phase reactants such as fibrinogen and serum amyloid A, leukocytosis and high level of erythrocyte sedimentation rate (ESR) are associated with periodic fever syndrome.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12190 

Diagnostic tools and genetic test are available for patients with periodic fever. For some conditions such as Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis Syndrome (PFAPA), no genetic test are available yet. Hereditary periodic fever syndromes (HPFSs) are rare and is characterized by short and recurrent attacks.

These attacks undergo remission without the use of antibiotic, anti-inflammatory, or immunosuppressive treatment. The patient feels healthy and is back to its daily routine until the next episode of periodic fever occurs.

Previously, there was no approved medicine for the treatment of TNF Receptor-Associated Periodic Syndrome (TRAPS), Hyperimmunoglobulinemia D Syndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD). In September 2016, the US Food and Drug Administration (FDA) has granted Novartis’ ilaris (canakinumab) expanded use for the treatment of these three rare and distinct types of Periodic Fever Syndromes.

Treatment with oral anti-inflammatory drugs, e.g. corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs), helps to control the symptoms but does not assist in the prevention of Periodic Fever Syndrome.

The global periodic fever syndrome is segmented on the basis of indication, treatment, end user, and geography:

Segmentation by Indication

  • Hyperimmunoglobulinemia D Syndrome (HIDS)
  • Familial Mediterranean Fever (FMF)
  • TNF Receptor-Associated Periodic Syndrome (TRAPS)
  • Cryopyrin-Associated Periodic Syndrome (CAPS)
  • Others

Segmentation by Treatment

  • Oral anti-inflammatory drugs (corticosteroid)
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Anti-TNF therapy
  • Statins
  • Others

Segmentation by End User

  • Hospitals
  • Retail pharmacy

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12190  

]]>
Increasing Consumer Awareness To Fuel Adoption Of Irrigated Ablation Catheter Market Wed, 19 Feb 2020 12:24:39 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620945.html http://zend.comunicati.net/comunicati/aziende/editoria/620945.html persistencemarketresearch persistencemarketresearch In February 2016, irrigated ablation catheter manufactured by Boston Scientific Corporation, received the approval from the US Food and Drug Administration. Irrigated ablation catheter is used to diagnose and treat a condition called type I atrial flutter. Atrial flutter is the condition the cause heart to beat too fast leading to heart failure or stroke. Some of the common symptoms include palpitations, presyncope, mild dyspnea, and fatigue.

Irrigation ablation catheter uses total tip cooling technology that is used to cool the catheter tip during the ablation procedure. In open irrigation catheter, radiofrequency energy is used to destroy the place in the tissue that causes atrial flutter.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12178  

Technological advancements, advanced product pipeline and growing awareness of patient safety and monitoring are some of the key drivers that are fuelling the growth of irrigated ablation catheter market. However, high research and development expenses in product development and the low awareness about irrigated ablation catheter in the developing countries is anticipated to hamper the growth of irrigated ablation catheter market.

According to National Center for Chronic Disease Prevention and Health Promotion, atrial fibrillation cost $6 billion each year in the United States. Medical expenses of people suffering from atrial fibrillation are about $8,705 higher per year compare to people who do not have atrial fibrillation.

Segmentation by Energy Sources

  • Radiofrequency (RF)
  • Cryoablation
  • Laser
  • Other Energy Sources (Microwave, High Intensity Focused Ultrasound (HIFU)),

Segmentation by Catheter Types

  • Single Point Radiofrequency Catheters
  • Multielectrode Radiofrequency Catheters
  • Contact Force Sensing Radiofrequency Catheters
  • Balloon Catheters

Segmentation by End User

  • Hospitals
  • Heart Center & Specialists

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12178 

]]>
Rising Demand From Consumers To Push Sales Of Dermal Regeneration Matrix Device Market Wed, 19 Feb 2020 12:24:16 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620943.html http://zend.comunicati.net/comunicati/aziende/editoria/620943.html persistencemarketresearch persistencemarketresearch Currently, topical antibiotics, skin grafting, wound dressings and tissue-engineered substitutes are available in the market that are used to treat skin-related disorders. A skin graft can be done by natural substitute such as amniotic membrane, potato peel or artificial material that includes synthetic polymer sheet, polymer foam or spray.

These substitute helps in the healing process. Skin regeneration refers to the regrowth of the damaged skin from the remaining tissue. Stem cell therapy has a vital application in skin regeneration.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12166  

Dermal regeneration matrix device provides an appropriate environment that is necessary for the proliferation and differentiation of skin cells. It helps in triggering the body‘s own repair mechanism by cell signaling, that drive the matrix environment in wound healing process.

Dermal regeneration matrix device is used to treat skin burns and is also finds application in reconstructive surgery for contractures (scars). The dermal regeneration matrix device is placed over the damaged skin which provides an environment for regeneration of new skin and tissue. The matrix is made of cow collagen, silicone and shark cartilage.

In 1996, the US Food and Drug Administration (FDA) first approved integrates dermal regeneration matrix device for treatment of burn injuries. In 2002, dermal regeneration matrix device was approved for use in reconstructive surgery for burn scars. About 30 million people in the US are suffering from diabetes, of which 15% experience a diabetic foot ulcer in their lifetime.

In January 2016, FDA approved the use of dermal regeneration matrix for treatment of chronic diabetic foot ulcers (DFU). The usage of dermal regeneration matrix device is expected to expand the growth of dermal regeneration matrix device owing to increase usage in chronic foot ulcer.

Technological advancement and continued research in the development of artificial skin promises to bring more products to the marketplace. Increasing adoption of the device and long-term benefits associated with its application are some of the factors expected to fuel growth of the global dermal regeneration matrix device market over the forecast period.  

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12166 

]]>
Increasing Consumer Adoption To Fuel Demand For Electroconvulsive Therapy Devices Market Wed, 19 Feb 2020 12:23:54 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620942.html http://zend.comunicati.net/comunicati/aziende/editoria/620942.html persistencemarketresearch persistencemarketresearch Though this treatment is said to be effective for many psychiatric disorder there are significant controversies related to this procedure. Some study have concluded ECT procedures just marginally more effective that other placebo procedures. This procedure is viewed harmful by general population and mental health professionals.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12127  

Despite of all the controversies ECT is used by the US and is endorsed by the American Psychiatric Association. Professional associations of Canada, Netherlands, Germany, Austria, Denmark and India have professional guidelines to use ECT.

ECT is performed on only selective patients with high degree of symptoms of severity and functional physical or mental disorders. It is also given to the patient who require treatment response urgently e.g. patients with suicidal behavior. It is also considered in the patients with treatment resistant cases of bipolar disorder. It is also used for the cases of acute schizophrenia.

This treatment is considered for the cases of schizophrenia patients who show minimal or no response to the antipsychotic medications. ECT is also recommended for the treatment of obsessive-compulsive disorder (OCD), catatonia, depression associated with Parkinson diseases, pain and acute confusion psychosis.

The increasing cases of mental illness due to brain injuries, Bacterial infections causing mental disorders and increasing long term use of substance abuse linked to depression and anxiety is expected to increase the usage of ECT device.

Changing life style and increasing exposure to harmful toxins is expected to attribute to the increasing usage of the device. The prevalence rate of schizophrenia was approximately 1.1% for the 18 years and above population in 2010. As per the report of the National Alliance on Mental Illness, 1 out of 5 adults in the US experience mental illness.

Growing incidence of mental disorders and demand for treatment options for severe mental illness are the factors driving the growth of global electroconvulsive therapy devices market . Advancements in technology and development for study of brain is believed to play the crucial role in the growth of global electroconvulsive therapy devices market over the forecast period. 

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12127 

]]>
Cardiopulmonary Autotransfusion Devices Market To Create Lucrative Opportunities For Existing Companies As Well As New Players Wed, 19 Feb 2020 12:23:32 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620940.html http://zend.comunicati.net/comunicati/aziende/editoria/620940.html persistencemarketresearch persistencemarketresearch Autotransfusion is also known as intraoperative blood salvage. It is a process in which blood is collected from active bleeding site of patient and reintegrated into the same patient during cardiac surgery. Several  commercial autotransfusion devices  are available in market.

There are three types of autotransfusion system namely; continuous flow centrifugal system, discontinuous flow centrifugal system and unwashed blood filter system. The unwashed blood filter system for autotransfusion is more popular than other systems because it is inexpensive system and easy to use.

This technology had led to increased use of centrifugation devices for blood collection. During cardiopulmonary bypass (CPB) blood is collected from patient active bleeding site by the help of suckers in different ways. This blood is collected in cardiotomy reservoir and it is filtered in this reservoir. Then this blood is redirected to venous reservoir where it is oxygenated and finally it is returned to patient body.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/12067

Autotransfusion involves the collection of blood before surgeries and its transfusion during cardiac. The increasing prevalence of cardiac diseases has led to rise in cardiac surgeries which has propelled the cardiopulmonary autotransfusion market globally. According to the American Heart Association, globally over 80 million people suffer from heart health problems.

This is occurring due to change in life style of people and consumption of high amount of fats and sugar. The complication in allogenic blood transfusion which results in significant loss of blood during cardiac surgery has led to the rise in demand for cardiopulmonary autotransfusion systems.

Beside that innovation in the autotransfusion system due to advancement in technology has also boosted the global market of cardiopulmonary autotransfusion devices. Lack of availability of skilled professional for operating cardiopulmonary autotransfusion devices can restrain the growth of this market.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/12067  

]]>
Demand For Oxygen Therapy Market From Key End-use Sectors To Surge Soon Wed, 19 Feb 2020 12:23:09 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620938.html http://zend.comunicati.net/comunicati/aziende/editoria/620938.html persistencemarketresearch persistencemarketresearch To understand how oxygen therapy is implemented in use, we need to understand the respiratory system. The respiratory system is a group of organs and tissues that help in breathing. The lungs and the nasal tract along with the wind pipe together form the respiratory system. The air enters the body through nose or mouth through the wind pipe to the lungs via bronchi.

The bronchi branches out into several tubes called bronchioles, which further branch out into tiny air sacs known as alveoli. These tiny air sacs are covered with a mesh of blood vessels called capillaries, which are connected to several arteries and veins which transfer oxygen throughout the body.

 To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11959  

Certain acute or chronic disease conditions, which affect the transfer of oxygen from alveoli to the blood, such a pneumonia, cystic fibrosis, asthma, dysplasia, heart failure, sleep apnea, lung disorders, and COPD (chronic obstructive pulmonary disease). Oxygen therapy is administered on the basis of arterial blood gas test and a pulse oximetry test.

According to the World Health Organization (WHO), total deaths due to COPD is expected to rise approximately by 30% in the next decade, thereby driving the need to incorporate oxygen therapy as a treatment option.

However it is estimated that COPD will be the third most fatal disease worldwide by 2024, thereby widening the consumer base for oxygen therapy market . The growing demand for technologically advanced system, such as portable oxygen concentrator system has also boosted global oxygen therapy market growth. Some of the major advancements include pulse oximetry devices, and nasopharyngeal oxygen therapy. 

The global Oxygen Therapy market is segmented on basis of product type, disease, administration device, end user, and geography:

  • Oxygen therapy market segmentation by Product type:
    • Compressed oxygen
    • Liquid Oxygen
    • Oxygen Concentrates
  • Oxygen therapy market segmentation by device:
    • Hyperbaric oxygen chamber
    • Nasal Cannula
    • Face mask
    • Trans-tracheal therapy
  • Oxygen therapy market segmentation on the basis of disease:
    • Respiratory Disorder:
      • Asthma
      • Dysplasia-Pacific
      • Cystic Fibrosis
      • COPD (Chronic Obstructive Pulmonary Disease)
    • Cardiovascular Disease
    • pneumonia
    • Sleep Apnea
    • Others
  • Oxygen therapy market segmentation by end User:
    • Hospitals
    • clinics
    • Rehab Centers
    • Home Healthcare.

 Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11959 

]]>
Oral Cancer Rapid Test Kit Market Report Explored In Latest Research Wed, 19 Feb 2020 12:22:46 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620937.html http://zend.comunicati.net/comunicati/aziende/editoria/620937.html persistencemarketresearch persistencemarketresearch The death rates due to oral cancer are relatively higher due to lack of proper diagnosis test, which can detect oral cancer at the early stage. Hence, early stage diagnosis is an alternative solution that helps prevent the deaths of people infected by oral cancer.

The Conventional diagnostic tests available in the market are time-consuming and costly. Currently, very few technologies are available in the market for routine screening of the oral cancers. Hence, companies are trying to develop the Oral Cancer Rapid Testing Kit (OCRTK) , which can detect the stage of cancer effectively in less time to perform test at home / clinic.  

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11908 

Vigilant biosciences developed 'OncAlert Oral Cancer LAB Test', which is accurate, cost effective, and uses non-invasive technology. This technology also got the CE mark in Europe that enables this product to sell all over Europe. Various companies and universities are trying to develop the rapid detection technology for oral cancer kits to detect oral cancer

The increase in usage of tobacco, which includes smokeless tobacco, HPV-induced cancers, and consumption of alcohol are major factors that drive the growth of the market. Furthermore, increase in awareness and aging population also contribute to the prevalence the oral cancers. According to the cancer research center in the UK, globally over 3, 00,000 persons were diagnosed with oral cancer. Smoking is a major factor that is turning many men and women into victims of Oral cancer.

In US, black males are having high incidence rate than their whiter counterparts because of cigarette smoking and heavy alcohol consumption. Lack of new diagnostic technologies in the market is a major factors that is limiting the growth of the OCRTK market.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11908 

]]>
Combined Angiography Market: Where Is The Market Heading? What Does The Future Hold For Players? Wed, 19 Feb 2020 12:22:24 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620936.html http://zend.comunicati.net/comunicati/aziende/editoria/620936.html persistencemarketresearch persistencemarketresearch It is commonly used for diagnosing the heart diseases such as  Coronary artery diseases . According to WHO, in 2012, 17.2 million people have died from cardiovascular diseases globally. Among them, 42.2% of the population were victims of the coronary artery disease.

Computed Tomography (CT), angiography, and Magnetic Resonance Imaging (MRI) angiography are new angiography techniques that are used to diagnose abnormalities in blood vessels. These procedures are heal comparatively faster than conventional X-ray angiography technique (digital subtraction angiography).

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11884  

However, in this procedure, only abnormalities in blood vessels are diagnosed whereas conventional angiography helps in diagnosing abnormalities and treating blocked arteries.

Hence, in recent years angiographic imaging system vendors have developed combined angiography device systems, which have both DSA and CT scan to treat and diagnose the blood vessel abnormalities.

These devices are present in two different operating rooms to diagnose and treat the blood vessel diseases due to which, most of the time is often lost in transferring the patients from the CT room (Diagnosis) to angio room (Treatment).

Hence, combined angiography system plays an important role in treating and diagnosing the patient in same operating room and reduces space for the equipment.

These systems have a new 3D-application which links the angiography systems with CT images previously taken during the interventional process. Hence, the systems provide exceptional imaging qualities and makes it easier for surgeons to conduct surgeries.

Few companies have developed mobile platforms to enable the multidisciplinary teams perform the procedures comfortably without any obligatory access to patients. In addition to these, systems will provide precision dosing, which expose the patient to less radiation as compared with the conventional system.

These systems have multiple-utility application areas, rising incidence of cardiac diseases, adaptation to new technologies and increasing awareness about the disease are the major factors driving the growth of combined angiography market.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11884 

]]>
How Will The Growth Unfold For Essential Tremor Treatment with Ultrasound Market Leaders? Wed, 19 Feb 2020 12:22:02 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620934.html http://zend.comunicati.net/comunicati/aziende/editoria/620934.html persistencemarketresearch persistencemarketresearch Treatment to relieve this disorder depends on their causes. Tremors can be treated by medicines or surgical procedure to improve muscles control. Essential tremors are not life threatening. However, they can be a cause of embarrassment and make it difficult to perform daily tasks. Treatment options for essential tremors are medication, deep brain stimulation (DBS), and thalamotomy.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11869  

Medication is first line treatment option for essential tremors. Focused ultrasound is a completely non-invasive treatment of thalamotomy, which could be more effective than other methods. Focused ultrasound is performed when patients are awake and involves no anesthesia, no incision in the scalp, and no burr holes through skull or insertion of electrode through brain during the treatment.

This provides a measure of safety because they can respond during the procedure. During focused ultrasound therapy, targeted cell in the thalamus are visualized in real time imaging. Focused beam of acoustic energy are used to heat and destroy target cells without impairing adjoining tissue.

Essential tremors treatment with ultrasound market is supposed to be driven by factors such as increase in age related neurological disorder. FDA approvals for clinical trials and huge inflow of new players entering the market is leading can be factor for growth of essential tremor treatment market with ultrasound. Advanced technology, improved clinical outcomes and awareness regarding consumer preferences are factors that drive the growth of essential tremor treatment with ultrasound market.

It is a non-invasive treatment that facilities patients to recover rapidly and perform day today task. Temporary sensory disturbances or lack of stability after treatment has been documented in can impact the growth of the market. Factor such as possibility of damage of other tissues can also restrain the growth of the essential tremor treatment with ultrasound market.

The global market of essential tremors treatment with ultrasound is segmented on the basis of indication end users and geographical region.

  • Segmentation by Indication
    • Head
    • trunk
    • Upper Extremity
    • Lower Extremity
    • Segmentation by End User
    • Hospitals
    • Ambulatory Surgical Centers
  • Segmentation by Region
    • North America
    • Latin America
    • europe
    • Asia Pacific
    • Middle East & Africa

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11869 

]]>
What Future Holds For Prenatal Testing Market? | Top Players To Be Benefited Wed, 19 Feb 2020 12:18:33 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620932.html http://zend.comunicati.net/comunicati/aziende/editoria/620932.html persistencemarketresearch persistencemarketresearch Prenatal testing  is a critical set of procedures during pregnancy in which screening tests detect the risk of possible health issues in the baby and a diagnosis test which affirms its presence. Prenatal tests are the routine tests with non-invasive screening and invasive procedures for the definitive prenatal diagnosis.

In modern perinatology there are many challenges such as chromosomal abnormalities, congenital heart conditions, and malformed kidneys and therefore to overcome the risks during prenatal pregnancy testing is conducted. There are different types of prenatal tests which can be categorized as the first trimester, second trimester, and third-trimester screening and diagnostic tests.

These tests are scheduled according to the days during pregnancy such as nine weeks to thirteen weeks and fourteen to eighteen weeks. Rapid evolving area of pregnancy care has led to the development of new and upgraded screening methods and diagnosis tests.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11725

Companies are more focusing on developing tests by a non-invasive approach to aid in detecting of increased number of abnormalities, allowing physicians to charge less.

According to Centers for Disease Control and Prevention, in 2012 the U.S. the rate of perinatal mortality was stable, stillbirth affects about 1% of all pregnancies and each year about 24,000 babies are stillborn. Medical care during pregnancy has improved over past decades but some issues regarding prenatal care are unchanged such as the rate of early stillbirth has remained about the same over time.

Creating awareness among countries about prenatal testing will aid in lowering the number of prenatal disorders shortly.

The global market for prenatal testing is segmented on the basis of test type and end user:

  • Segmentation by test type of prenatal testing
    • First-trimester screening tests
      • Cell-free fetal DNA testing
      • Early ultrasound
      • Cystic fibrosis
    • Second-trimester screening tests
      • Quad Screen Test
      • Amniocentesis
      • Ultrasound
      • Glucose Screening
    • Third-trimester Screening Tests
      • Group B Strep Screening
    • Diagnostic tests
      • Chorionic villus sampling
    • Segmentation by End user of prenatal testing
      • Hospitals
      • Pathology Labs
      • Gynecology Clinics
      • Research Organizations

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11725  

]]>
Head and Neck Cancer Therapeutics Market: Exploring The Impact Of Trends On Strategies Of Key Players Wed, 19 Feb 2020 12:18:11 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620930.html http://zend.comunicati.net/comunicati/aziende/editoria/620930.html persistencemarketresearch persistencemarketresearch Head and neck cancer is the sixth most common type of cancer and accounts for 56% of all cancers. Treatment of head and neck cancer presents a significant challenge to physicians as the choice of treatment varies from patient to patient and location of the tumor.

Head and neck cancers ate often treated with surgery, but the complexity of facial structures and functions limits the surgical treatments. Surgery for head and neck cancer changes some of the functions such as chewing, swallowing, talking, etc. Surgical therapy in combination with radiation therapy is the most preferred treatment regimen by physicians.

To Remain 'Ahead' Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11734  

However, currently available treatment options for head and neck cancer do not result in improvement in survival rate, and head and neck cancer survival rate has decreased from 80% to 50% in last ten years.

Recent developments in advanced chemotherapy and radiotherapy allow preserving some of the functions of the face. The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, antibody drug conjugates, etc. has opened up huge potential for the growth of head and neck cancer therapeutics market . 

Growing incidence of head and neck cancer and demand for cost-effective treatment options are the factors driving the growth of global head and neck cancer therapeutic market.

According to Globocan 2012, globally, 521,983 new cases of the lip, oral cavity, and larynx cancer were diagnosed in 2012. Advancements in technology and development of new targeted molecules are believed to play the crucial role in the growth of global head and neck cancer therapeutics market over the forecast period.

 Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11734 

]]>
How Transformative Trends In Bone Metastasis Therapeutics Market Are Molding Strategies Of Consumers? Wed, 19 Feb 2020 12:17:48 +0100 http://zend.comunicati.net/comunicati/aziende/editoria/620929.html http://zend.comunicati.net/comunicati/aziende/editoria/620929.html persistencemarketresearch persistencemarketresearch The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor.

Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/11731

Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries.

According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents.

A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.

The global market for bone metastasis therapeutics has been segmented on basis of treatment type, end user, and geography:

Based on treatment type, the global bone metastasis therapeutics market is segmented into following :

  • Drug Treatment
    • Pain Relievers
      • NSAIDs
      • opioids
    • Bone Building medications
      • corticosteroids
      • bisphosphonates
        • Teriparatide
        • Pamidronate
        • Medronate
    • Targeted Therapy Agents
  • Tumor Ablation Therapy
    • Radiofrequency ablation
    • Cryoablation
  • Surgery
  • Osteoplasty
  • Orthopedic Fixation

Based on end user, the global bone metastasis therapeutics market is segmented into following :

  • Hospitals
  • Cancer Rehabilitation Centers
  • Specialty Clinics
  • Ambulatory Surgical Centers

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/11731  

]]>